256 related articles for article (PubMed ID: 37021281)
1. Pediatric immune-mediated necrotizing myopathy.
Wang CH; Liang WC
Front Neurol; 2023; 14():1123380. PubMed ID: 37021281
[TBL] [Abstract][Full Text] [Related]
2. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
3. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies.
Julien S; Challier I; Malleter M; Jouen F; Drouot L; Boyer O
Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390873
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
6. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
[TBL] [Abstract][Full Text] [Related]
7. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
8. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
Ma X; Bu BT
Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
[TBL] [Abstract][Full Text] [Related]
9. Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (Anti-HMG CoA) Myopathy With Cardiac Involvement: Presentation, Diagnosis, and Management.
Liu L; Tessier S; Ido F; Longo S; Nanda S
Cureus; 2022 Mar; 14(3):e23125. PubMed ID: 35425681
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy.
Khan N; Kazmi Z
Qatar Med J; 2022; 2022(1):6. PubMed ID: 35261909
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
Anquetil C; Boyer O; Wesner N; Benveniste O; Allenbach Y
Autoimmun Rev; 2019 Mar; 18(3):223-230. PubMed ID: 30639649
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series.
Xiong A; Yang G; Song Z; Xiong C; Liu D; Shuai Y; He L; Zhang L; Guo Z; Shuai S
Ther Adv Neurol Disord; 2021; 14():1756286421998918. PubMed ID: 33786066
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
[TBL] [Abstract][Full Text] [Related]
15. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
Cui BB; Tian YR; Ma XY; Yin G; Xie Q
Front Immunol; 2021; 12():777502. PubMed ID: 34925350
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy.
Ge Y; Yang H; Jiang W; Tian X; Lu X; Wang G
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231181336. PubMed ID: 37465567
[TBL] [Abstract][Full Text] [Related]
17.
Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of immune-mediated necrotizing myositis.
Weeding E; Tiniakou E
Curr Treatm Opt Rheumatol; 2021 Jun; 7(2):150-160. PubMed ID: 34422547
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated necrotizing myopathy.
Bergua C; Chiavelli H; Simon JP; Boyer O; Jouen F; Stenzel W; Martinet J
Z Rheumatol; 2016 Mar; 75(2):151-6. PubMed ID: 26783154
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
